Judge Rules Visa Improperly Canceled for Harvard Scholar Kseniia Petrova at Boston Logan

(BOSTON, MASSACHUSETTS) — A federal judge ruled on April 7, 2026 that U.S. Customs and Border Protection improperly canceled Harvard researcher Kseniia Petrova’s J-1 research visa after officers detained her at Boston Logan International Airport with frog embryos she had not declared.

U.S. District Court Judge Christina Reiss found that the cancellation was “arbitrary and capricious” and said CBP exceeded its authority when it revoked Petrova’s visa over the biological samples, according to the ruling in Petrova v. Mayorkas et al. in the U.S. District Court for the District of Vermont.

The decision marked a legal win for Petrova, a Russian-born scientist at Harvard University, even as a separate criminal case against her continues in Massachusetts. Federal prosecutors charged her on June 25, 2025 with concealment of a material fact, false statement and smuggling goods into the United States.

Petrova’s case began on February 16, 2025, when she arrived at Logan Airport from Paris. A K-9 unit alerted officers to her bag, which contained a foam box of clawed frog embryos in microcentrifuge tubes and slides.

Her legal team argued she made a minor clerical error by failing to list the samples on her customs declaration form, a lapse they said typically results in a fine of $50 to $500. Reiss rejected the government’s use of that customs issue as grounds to cancel the visa and place her into expedited removal.

“The undisputed facts reveal that Ms. Petrova’s visa was impermissibly canceled because of the frog embryo samples and for no other reason,” Reiss wrote.

That finding put the dispute over CBP authority at the center of the case. Reiss said officers at ports of entry have limited power over visa cancellations and cannot use suspected customs violations as a pretext to sidestep ordinary immigration procedures.

The ruling carried weight beyond one case because it touched on how far border officers can go when they suspect wrongdoing by travelers entering the United States. It also drew notice in academic circles because the materials Petrova carried were tied to research at Harvard’s Kirschner Lab.

Colleagues there testified that the samples were non-living, non-toxic spliced sections of Xenopus embryos and were important for work on cell renewal and cancer. Harvard faculty described Petrova’s expertise in genome biology as “irreplaceable.”

The Department of Homeland Security defended the detention after the ruling. “Ms. Petrova was lawfully detained after lying to federal officers about carrying substances into the country. President Donald Trump’s administration remains committed to restoring the rule of law and common sense to our immigration system,” a DHS spokesperson said on April 8, 2026.

DHS had made similar allegations earlier in the case. In a statement on X on May 14, 2025, the department said Petrova was detained after “lying to federal officers about carrying substances into the country.” The department also said messages on her phone “revealed she planned to smuggle the materials through customs without declaring them.”

Federal prosecutors laid out the criminal accusations in a June 25, 2025 indictment announcement by the U.S. Attorney’s Office for the District of Massachusetts. The office said, “Kseniia Petrova, 31, a Russian citizen, was indicted on one count of concealment of a material fact, one count of false statement and one count of smuggling goods into the United States. [Petrova] initially denied carrying any biological material in her checked baggage [but] later admitted it.”

An earlier DOJ press release on the initial charges also outlined the government’s allegations in the case.

Those criminal charges remain separate from the visa dispute that Reiss decided. If convicted of smuggling under 18 U.S.C. § 545, Petrova faces up to 20 years in prison and a $250,000 fine.

The judge’s ruling did not erase those charges, but it directly rejected the government’s handling of Petrova’s immigration status at the airport. In practical terms, the decision drew a line between customs enforcement and visa revocation.

That distinction mattered because Petrova had entered the United States on a J-1 research visa, a category widely used by scholars, scientists and exchange visitors. The case raised questions among lawyers and universities about how administrative mistakes at ports of entry could affect foreign researchers.

Petrova spent four months in detention from February to June 2025, primarily at the Richwood Correctional Center in Louisiana, before she won release on bail. By January 2026, she had returned to her lab at Harvard, though she remained under pretrial supervision with travel restrictions.

Her detention drew wider attention because of her personal background as well as the scientific stakes. Petrova, an anti-war activist who fled Russia, feared deportation would expose her to political persecution in her home country.

That concern added a political dimension to a case already watched closely by scientists and immigration lawyers. Critics cast the matter as part of a broader crackdown on foreign researchers, while the government framed it as a case of deception at the border.

For Harvard, the dispute reached beyond one laboratory. The university monitored the case closely as faculty members argued that losing Petrova would damage ongoing work and send a message to international scholars weighing whether to come to the United States.

Attorneys involved in the matter said the case could deter researchers from seeking positions at American institutions if minor paperwork mistakes trigger aggressive enforcement. That concern has echoed across universities that depend heavily on foreign-born scientists working under temporary research visas.

At the center of Reiss’s decision was the judge’s view that CBP’s powers, while broad, are not unlimited. She said the government could not transform a customs issue involving undeclared biological materials into a basis for ending Petrova’s immigration status without lawful grounds.

The ruling also sharpened attention on what officers found and how they treated the omission. The items in Petrova’s baggage were frog embryos stored in microcentrifuge tubes and slides, materials tied to academic research rather than commercial trafficking.

Her lawyers described the failure to declare them as an administrative lapse that normally brings a modest civil penalty, not visa cancellation and detention. Reiss’s order aligned with that narrower view of the customs problem, even as the government continued to press its criminal case.

The case file in Vermont, Petrova v. Mayorkas et al., now stands as a court reference for lawyers examining limits on border authority over visa holders. In Massachusetts, prosecutors continue to pursue the indictment announced last year.

The government has relied on statements Petrova allegedly made to officers and messages found on her phone. DHS and DOJ have both maintained that she tried to bring the materials into the country without declaring them.

Petrova’s supporters, meanwhile, have focused on the samples themselves and the role they played in Harvard research. The work in the Kirschner Lab involved cell renewal and cancer, making the seized materials part of a scientific project that colleagues said could not easily proceed without her knowledge.

That combination of border enforcement, immigration law and academic research turned a single airport stop into a test case with wider implications. For universities, it raised concern about how quickly an encounter at a port of entry can disrupt a lab, a career and an institution’s recruitment efforts.

For Petrova, the practical effect has been months of detention, criminal charges still pending and limits on her travel even after her return to the lab. For the government, the judge’s ruling was a setback in its handling of her visa, but not the end of the prosecution.

Reiss’s order left one point unmistakable in the immigration fight: “The undisputed facts reveal that Ms. Petrova’s visa was impermissibly canceled because of the frog embryo samples and for no other reason.”